Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Barbara Schütt"'
Autor:
Torsten Zimmermann, Manuela Casjens, Marcus-Hillert Schultze-Mosgau, Stephanie Loewen, Corinna Draeger, Barbara Schütt, Beate Rohde
Publikováno v:
British Journal of Clinical Pharmacology. 87:925-936
Aim The primary objective was to explore whether the suppression of ovarian activity induced by a combined oral contraceptive (COC) is influenced by the simultaneous intake of the selective progesterone receptor modulator (SPRM) vilaprisan (VPR). Met
Criticality Metrics for Automated Driving: A Review and Suitability Analysis of the State of the Art
Autor:
Lukas Westhofen, Christian Neurohr, Tjark Koopmann, Martin Butz, Barbara Schütt, Fabian Utesch, Birte Neurohr, Christian Gutenkunst, Eckard Böde
The large-scale deployment of automated vehicles on public roads has the potential to vastly change the transportation modalities of today’s society. Although this pursuit has been initiated decades ago, there still exist open challenges in reliabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d482d6afc4586d40e3bb8ccda06652d1
http://arxiv.org/abs/2108.02403
http://arxiv.org/abs/2108.02403
Autor:
Andreas Kaiser, Barbara Schütt, Beate Rohde, Marcus-Hillert Schultze-Mosgau, Corinna Draeger, Stephanie Löwen, Xinying Chang
Publikováno v:
Journal of Clinical Pharmacology
This randomized, double‐blind, parallel‐group study in healthy young women investigated the effect of treatment with vilaprisan (0.5, 1, 2, or 4 mg/day for 12 weeks) on ovarian function by assessing the Hoogland score, which is based on the size
Autor:
Manuela Koch, Christian Seitz, Barbara Schütt, Andreas Kaiser, Beate Rohde, Marcus-Hillert Schultze-Mosgau, David Bell
Publikováno v:
Human Reproduction. 31:1703-1712
STUDY QUESTION Does administration of vilaprisan (VPR) to healthy women for 12 weeks reduce menstrual bleeding? SUMMARY ANSWER In this 12-week proof-of-concept phase 1 trial, most women (30/33, 90%) who received VPR at daily doses of 1-5 mg reported
Autor:
Simone Gschwend, Frank S. Zollmann, Matthias Berse, Joachim Höchel, Stefan Klein, Barbara Schütt, Wiesinger Herbert
Publikováno v:
British Journal of Clinical Pharmacology. 80:1399-1410
Aims The present study was conducted to investigate the influence of the strong CYP3A4 inhibitor ketoconazole (KTZ) on the pharmacokinetics of drospirenone (DRSP) administered in combination with ethinylestradiol (EE) or estradiol (E2). Methods This
Autor:
Herbert, Wiesinger, Matthias, Berse, Stefan, Klein, Simone, Gschwend, Joachim, Höchel, Frank S, Zollmann, Barbara, Schütt
Publikováno v:
British journal of clinical pharmacology. 80(6)
The present study was conducted to investigate the influence of the strong CYP3A4 inhibitor ketoconazole (KTZ) on the pharmacokinetics of drospirenone (DRSP) administered in combination with ethinylestradiol (EE) or estradiol (E2).This was a randomiz
Publikováno v:
IEEE Access, Vol 10, Pp 18631-18644 (2022)
Ensuring the quality of automated driving systems is a major challenge the automotive industry faces. In this context, quality defines the degree to which an object meets expectations and requirements. Especially, highly automated and automated vehic
Externí odkaz:
https://doaj.org/article/adce41294a2f4872935756384cbdc9a3
Publikováno v:
Journal of clinical pharmacology. 47(6)
The effect of drospirenone on plasma potassium when coadministered with nonsteroidal anti-inflammatory drugs, such as indomethacin, is unknown. An open-label crossover study investigated the effects of estradiol/drospirenone and indomethacin coadmini
Autor:
Barbara I. Streibl, Heidi Lahne, Andreas Grahl, Philipp Agsten, Magdalena Bichler, Christa Büchl, Marco Damzog, Ute Eberle, Stefan Gärtner, Bernhard Hobmaier, Gabriele Margos, Martin Hoch, Sabrina Jungnick, Walter Jonas, Katharina Katz, Liane Laubert, Barbara Schutt, Cornelia Seidl, Bianca Treis, Daniel Weindl, Karen Zilch, Manfred Wildner, Bernhard Liebl, Nikolaus Ackermann, Andreas Sing, Volker Fingerle
Publikováno v:
Microorganisms, Vol 10, Iss 9, p 1809 (2022)
Background: Despite a vaccination rate of 82.0% (n = 123/150), a SARS-CoV-2 (Alpha) outbreak with 64.7% (n = 97/150) confirmed infections occurred in a nursing home in Bavaria, Germany. Objective: the aim of this retrospective cohort study was to exa
Externí odkaz:
https://doaj.org/article/9b01a075cbb547f8b8a663c5dddd4c3c